Clinical Application and Potential of Fecal Microbiota Transplantation - PubMed (original) (raw)
Review
Clinical Application and Potential of Fecal Microbiota Transplantation
R E Ooijevaar et al. Annu Rev Med. 2019.
Abstract
Fecal microbiota transplantation (FMT) is a well-established treatment for recurrent Clostridioides difficile infection. FMT has become a more readily available and useful new treatment option as a result of stool banks. The current state of knowledge indicates that dysbiosis of the gut microbiota is implicated in several disorders in addition to C. difficile infection. Randomized controlled studies have shown FMT to be somewhat effective in treating ulcerative colitis, irritable bowel syndrome, and hepatic encephalopathy. In addition, FMT has been beneficial in treating several other conditions, such as the eradication of multidrug-resistant organisms and graft-versus-host disease. We expect that FMT will soon be implemented as a treatment strategy for several new indications, although further studies are needed.
Keywords: infection; CDI; FMT; IBD; IBS; fecal microbiota transplantation; hepatic encephalopathy; inflammatory bowel disease; irritable bowel syndrome.
Similar articles
- Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
Juszczuk K, Grudlewska K, Mikucka A, Gospodarek E. Juszczuk K, et al. Postepy Hig Med Dosw (Online). 2017 Mar 27;71(0):220-226. doi: 10.5604/01.3001.0010.3807. Postepy Hig Med Dosw (Online). 2017. PMID: 28345530 Review. - [Faecal microbiota transplantation for the treatment of bowel disease].
Rode AA, Chehri M, Petersen AM, Bytzer P. Rode AA, et al. Ugeskr Laeger. 2017 Jul 31;179(31):V03170218. Ugeskr Laeger. 2017. PMID: 28869008 Review. Danish. - Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
Kump P, Högenauer C. Kump P, et al. Dig Dis. 2016;34 Suppl 1:74-81. doi: 10.1159/000447379. Epub 2016 Aug 22. Dig Dis. 2016. PMID: 27548724 - Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
Holleran G, Scaldaferri F, Ianiro G, Lopetuso L, Mc Namara D, Mele MC, Gasbarrini A, Cammarota G. Holleran G, et al. Drugs Today (Barc). 2018 Feb;54(2):123-136. doi: 10.1358/dot.2018.54.2.2760765. Drugs Today (Barc). 2018. PMID: 29637938 Review. - Fecal microbiota transplantation: past, present and future perspectives.
Bibbò S, Ianiro G, Gasbarrini A, Cammarota G. Bibbò S, et al. Minerva Gastroenterol Dietol. 2017 Dec;63(4):420-430. doi: 10.23736/S1121-421X.17.02374-1. Minerva Gastroenterol Dietol. 2017. PMID: 28927251 Review.
Cited by
- Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial.
Kwak S, Choi J, Hink T, Reske KA, Blount K, Jones C, Bost MH, Sun X, Burnham CD, Dubberke ER, Dantas G; CDC Prevention Epicenter Program. Kwak S, et al. Microbiome. 2020 Aug 31;8(1):125. doi: 10.1186/s40168-020-00907-9. Microbiome. 2020. PMID: 32862830 Free PMC article. Clinical Trial. - Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome.
Wang Y, Zheng F, Liu S, Luo H. Wang Y, et al. Gastroenterol Res Pract. 2019 Dec 1;2019:9759138. doi: 10.1155/2019/9759138. eCollection 2019. Gastroenterol Res Pract. 2019. PMID: 31885549 Free PMC article. Review. - Crosstalk between gut microbiota and metastasis in colorectal cancer: implication of neutrophil extracellular traps.
Wu J, Dong W, Pan Y, Wang J, Wu M, Yu Y. Wu J, et al. Front Immunol. 2023 Oct 23;14:1296783. doi: 10.3389/fimmu.2023.1296783. eCollection 2023. Front Immunol. 2023. PMID: 37936694 Free PMC article. Review. - Research progress and treatment of radiation enteritis and gut microbiota.
Ren H, Wu Q, Sun Z, Fang M, Liu J, Luo J. Ren H, et al. Radiat Oncol J. 2023 Jun;41(2):61-68. doi: 10.3857/roj.2023.00346. Epub 2023 Jun 28. Radiat Oncol J. 2023. PMID: 37403348 Free PMC article.